

























![]()
Q2: 2026-05-07 Earnings Summary
EPS of $2.90 beats by $0.13
|
Revenue of
$4.71B
(-10.58% Y/Y)
beats by $42.23M
Becton, Dickinson and Company (BDX) Bank of America Global Healthcare Conference 2026 May 12, 2026 11:40 AM EDT
Company Participants
Vitor Roque - Executive VP & CFO
Thomas Polen - President, CEO & Chairman
Conference Call Participants
Travis Steed - BofA Securities, Research Division
Presentation
Travis Steed
BofA Securities, Research Division
Travis Steed, the medical device analyst at Bank of America. Next up, we have Becton, Dickinson, Tom Polen, CEO; and Vitor Roque, the newly announced CFO. I think you've been to Vegas a couple of times, but this is his first fireside chat as CFO. So welcome.
Vitor Roque
Executive VP & CFO
Thank you. Thanks for having me.
Question-and-Answer Session
Travis Steed
BofA Securities, Research Division
Maybe since it is your first fireside chat. Maybe we'll start with you just announced permanent CFO. Just kind of love to talk about your strategy as CFO. What do you think is different? What do you think is the same as we see BDX in this role?
Vitor Roque
Executive VP & CFO
Sure. No, thanks for the question, and thanks for having me. Very happy to be taking this new role as Chief Financial Officer in the search of pivotal time for BD. We just closed the transaction with Life Sciences last quarter, and we couldn't be happier with the new strategy that BD is taking.
From a CFO perspective, I think the philosophy here is to be making sure that we are like consistent and transparent, making sure that we understand the business drivers. And I actually feel that I'm very well positioned to do that given my more than 2 decades with the organization, and I can partner with Tom and the leadership team in order to drive that operation and unlock the growth that we are looking for while being very responsible, and
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。